|
Daniel Kisner is a Partner at Aberdare Ventures. Prior to joining Aberdare Ventures as Partner in 2002, he was President and Chief Executive Officer of Caliper Technologies, now Caliper Life Sciences, where he is still Chairman of the Board. Prior to that he was President and Chief Operating Officer of Isis Pharmaceuticals. Earlier positions in large pharma include that of Division Vice President of Pharmaceutical Development at Abbott Laboratories and Vice President of Clinical Research at SmithKline Beckman. Earlier he held a tenured position in the Division of Oncology at the University of Texas at San Antonio School of Medicine. Dr. Kisner is certified by the American Board of Internal medicine and Medical Oncology. Dr. Kisner holds an A.B. from Rutgers University and an M.D. from Georgetown University. | 